文献速递前列腺癌

挽救性机器人辅助根治性前列腺切除术的技术与结局

Techniques and Outcomes of Salvage Robot-Assisted Radical Prostatectomy (sRARP).
PubMed 文献 · Eur Urol · 2020-05-24

该研究回顾性分析了106例局部复发的前列腺癌患者接受挽救性机器人辅助根治性前列腺切除术(sRARP)的围手术期、功能与肿瘤学结局。中位随访2.1年,90天并发症率8%,2年及以上完全控尿率50%、社交控尿率33%,勃起功能障碍95%,切缘阳性率39%,生化复发13%,局部或转移复发11%。结论认为sRARP技术上更具挑战性但可行,功能结局劣于初次RARP。

要点

  • sRARP术后功能结局劣于初次RARP,需充分告知患者。
  • 根据既往治疗调整手术技术是获得良好手术结局的关键。
  • sRARP在高流量中心是局部复发前列腺癌的可行选择。

核心结论

  • sRARP技术上更具挑战性,但在高流量中心是治疗复发性前列腺癌的可行选择。
  • 患者功能结局劣于初次RARP,术前咨询应明确告知。
  • 根据初次治疗调整手术技术是获得良好手术结局的关键。

研究设计与样本

  • 回顾性评估106例适合sRARP的局部复发前列腺癌患者。
  • 手术使用DaVinci Si系统,类似标准方法但根据初次治疗进行调整。

主要发现

  • 初次治疗为HIFU 59例(56%)、放疗27例(25%)、种子近距离放疗10例(9%)、单独ADT 8例(8%)、冷冻治疗1例(1%)、电穿孔/Nanoknife 1例(1%)。
  • 中位随访2.1年,90天并发症率为8%。
  • 2年及以上完全控尿率50%,社交控尿率33%,勃起功能障碍率95%。
  • 切缘阳性率39%,生化复发率13%,局部或转移复发率11%。
  • 局灶治疗后的控尿率倾向于优于全腺体治疗。

临床怎么用

  • sRARP可用于局部复发前列腺癌的治疗,但需在高流量中心由经验丰富的医生实施。
  • 术前应告知患者功能结局(控尿和勃起功能)劣于初次RARP。
  • 手术技术应根据初次治疗类型进行个体化调整。

局限性

  • 回顾性研究设计。
  • 样本量有限(106例)。
  • 中位随访时间较短(2.1年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salvage Robot-Assisted Radical Prostatectomy (sRARP) has been described as feasible treatment for the management of localised prostate cancer (PCa) recurrence after primary treatment. However, no large reports have published cancer and quality outcomes. OBJECTIVE: To report perioperative, functional and oncologic outcomes of sRARP in patients with localised PCa recurrence. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively evaluated 106 patients with local recurrence eligible for sRARP. SURGICAL PROCEDURE: Surgery was performed using the DaVinci Si system similar to the standard approach but with adaptation to the primary treatment. MEASUREMENTS: Peri-operative outcomes included 90-day complication rate. Functional outcomes included rates of incontinence and erectile dysfunction. Oncological outcomes included tumour staging, margin rate and recurrence. RESULTS AND LIMITATIONS: Primary treatment was High Intensity Focused Ultrasound (HIFU) in 59 (56%) patients, 27 (25%) radiotherapy, 10 (9%) seed brachytherapy, 8 (8%) solitary androgen deprivation therapy (ADT), one (1%) cryotherapy and one (1%) electroporation / Nanoknife. Median follow-up was 2.1 years. 90-day complication rate was 8%. At two years or more, 50% were fully continent and 33% were socially continent. Continence rates tended to be better after focal compared to whole-gland treatments. Erectile dysfunction was present in 95%. Positive surgical margin rate was 39%. Biochemical recurrence occurred in 13% and local or metastatic recurrence in 11%. CONCLUSIONS: sRARP is technically more challenging but is a feasible option in high-volume centres for treatment of recurrent PCa. Patients should be counselled that functional outcomes are inferior to primary RARP. Adjustment of surgical technique according to the primary treatment is key for good surgical outcomes. PATIENT SUMMARY: We report our experience with sRARP for the management of localised PCa recurrence after primary treatment. This represents a feasible approach with acceptable peri-operative complications and cancer outcomes. Functional outcomes are inferior to RARP in the primary setting.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. De Groote R, Nathan A, De Bleser E, et al. Techniques and Outcomes of Salvage Robot-Assisted Radical Prostatectomy (sRARP). Eur Urol. 2020. PMID: 32461073. doi:10.1016/j.eururo.2020.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。